CLINICAL_TRIALS
ClinicalTrials.gov record update
Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01533948
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:56.304863+00:00
- Published At
- 2018-05-09T00:00:00+00:00
- Record Updated At
- 2018-05-09
- Results Posted At
- 2018-05-09
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Extraocular Extension Melanoma", "Metastatic Intraocular Melanoma", "Recurrent Intraocular Melanoma", "Recurrent Melanoma", "Stage IIIA Intraocular Melanoma", "Stage IIIA Melanoma", "Stage IIIB Intraocular Melanoma", "Stage IIIB Melanoma", "Stage IIIC Intraocular Melanoma", "Stage IIIC Melanoma", "Stage IV Intraocular Melanoma", "Stage IV Melanoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-09"- protocolSection.identificationModule.nctId
"NCT01533948"- protocolSection.identificationModule.officialTitle
"Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-05-09"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.